| Name | Title | Contact Details |
|---|---|---|
Pat Costello |
General Counsel | Profile |
Jimmy Holland |
Deputy General Counsel | Profile |
Henry Huffnagle |
Vice President and Associate General Counsel, Head of Commercial Contracts | Profile |
Parcel Pending provides a comprehensive, automated solution to the growing package management problems facing multi-family housing communities. The company`s electronic locker storage system eliminates the need for management to handle resident`s packages and enables residents to pick up their packages 24/7 at their apartment community.
Maximize cross-media revenue with machine intelligence. Maximize inventory value across all properties, enhance audience values with pinpoint targeting, optimize campaigns across all platforms
Mathison is the only end-to-end hiring solution for diversity, equity and inclusion. Set DEI goals and take action. Mobilize and train your entire team.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Brooks-Durham is a Annandale, NJ-based company in the Software and Internet sector.